It took 60 years, but RSV vaccines are just around the corner — and could make a big difference

A newly approved vaccine for older adults, as well as other potential treatments to protect infants, could make a monumental difference in the number of people being hospitalized and dying from RSV, infectious disease and public health experts say. 

Related Keywords

Canada ,Toronto ,Ontario ,Canadian ,Sabina Vohra Miller ,Brian Goldman ,Fiona Brinkman ,Jaec Hong ,Jesse Papenburg ,Young ,Astrazeneca ,National Institutes Of Health ,National Institute Of Allergy ,Canadian Agency For Drugs ,Technology In Health ,Associated Press ,Simon Fraser University ,National Advisory Committee On Immunization ,University Of Toronto ,Drug Administration ,Health Canada ,Pfizer ,Mcgill University Health Centre ,New England Journal ,Unambiguous Science ,Mcgill University Health ,National Institutes ,National Institute ,Infectious Diseases ,Simon Fraser ,Canadian Agency ,National Advisory Committee ,